Cargando…

Inhibition of tRNA Gene Transcription by the Immunosuppressant Mycophenolic Acid

Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil, a drug that is widely used for immunosuppression in organ transplantation and autoimmune diseases, as well as anticancer chemotherapy. It inhibits IMP dehydrogenase, a rate-limiting enzyme in de novo synthesis of guanidine nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jurkiewicz, Aneta, Leśniewska, Ewa, Cieśla, Małgorzata, Gorjão, Neuton, Kantidakis, Theodoros, White, Robert J., Boguta, Magdalena, Graczyk, Damian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908259/ https://www.ncbi.nlm.nih.gov/pubmed/31658995 http://dx.doi.org/10.1128/MCB.00294-19

Ejemplares similares

Novel layers of RNA polymerase III control affecting tRNA gene transcription in eukaryotes
por: Leśniewska, Ewa, et al.
Publicado: (2017)

Function of TFIIIC, RNA polymerase III initiation factor, in activation and repression of tRNA gene transcription
por: Cieśla, Małgorzata, et al.
Publicado: (2018)

Global analysis of transcriptionally engaged yeast RNA polymerase III reveals extended tRNA transcripts
por: Turowski, Tomasz W., et al.
Publicado: (2016)

Dr1 (NC2) is present at tRNA genes and represses their transcription in human cells
por: Kantidakis, Theodoros, et al.
Publicado: (2010)

Reprogramming mRNA Expression in Response to Defect in RNA Polymerase III Assembly in the Yeast Saccharomyces cerevisiae
por: Rudzińska, Izabela, et al.
Publicado: (2021)

The Aminoacyl-tRNA Synthetase and tRNA Expression Levels Are Deregulated in Cancer and Correlate Independently with Patient Survival
por: Sangha, Anmolpreet Kaur, et al.
Publicado: (2022)

Inhibition of RNA Polymerase III Augments the Anti-Cancer Properties of TNFα
por: Nair, Hitha Gopalan, et al.
Publicado: (2023)

RNA polymerase III transcription is repressed in response to the tumour suppressor ARF
por: Morton, Jennifer P., et al.
Publicado: (2007)

Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents
por: Walczak, Juliusz Maksymilian, et al.
Publicado: (2022)

Control of Saccharomyces cerevisiae pre-tRNA processing by environmental conditions
por: Foretek, Dominika, et al.
Publicado: (2016)

Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression
por: Khan, Muhammad Saad, et al.
Publicado: (2020)

The expression of Rpb10, a small subunit common to RNA polymerases, is modulated by the R3H domain-containing Rbs1 protein and the Upf1 helicase
por: Cieśla, Małgorzata, et al.
Publicado: (2020)

Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease
por: Taylor, Erin B., et al.
Publicado: (2017)

Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal, Asma, et al.
Publicado: (2020)

CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases
por: Patel, Prem N., et al.
Publicado: (2023)

Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid
por: de Ruiter, Petra E, et al.
Publicado: (2018)

The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model
por: Heischmann, Svenja, et al.
Publicado: (2017)

Mycophenolic Acid Derivatives with Immunosuppressive Activity from the Coral-Derived Fungus Penicillium bialowiezense
por: Zhang, Qing, et al.
Publicado: (2018)

Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases
por: Li, Yuce, et al.
Publicado: (2021)

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension
por: Satou, Ryousuke, et al.
Publicado: (2022)

Maf1-mediated regulation of yeast RNA polymerase III is correlated with CCA addition at the 3′ end of tRNA precursors
por: Foretek, Dominika, et al.
Publicado: (2017)

Evaluation on physiological biomarkers pre and during gestational period in immunosuppressed Wistar rats with mycophenolate sodium
por: Deluque, Amanda Lima, et al.
Publicado: (2015)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics
por: Feturi, Firuz G., et al.
Publicado: (2018)

RECQL5 Controls Transcript Elongation and Suppresses Genome Instability Associated with Transcription Stress
por: Saponaro, Marco, et al.
Publicado: (2014)

Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study
por: Hanisch, F, et al.
Publicado: (2009)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Successful Triple Combination Immunosuppressive Therapy with Prednisolone, Cyclosporine, and Mycophenolate Mofetil to Treat Recurrent Giant Cell Myocarditis
por: Akita, Tomomi, et al.
Publicado: (2019)

Immunosuppressant mycophenolic acid biosynthesis employs a new globin-like enzyme for prenyl side chain cleavage
por: Chen, Xiwei, et al.
Publicado: (2019)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults
por: Groll, Andreas H., et al.
Publicado: (2016)

Fear of stinging insects in relation to state anxiety and trait anxiety in a group of patients with hymenoptera venom allergy undergoing immunotherapy
por: Woźniewicz, Agnieszka, et al.
Publicado: (2019)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Why Are tRNAs Overproduced in the Absence of Maf1, a Negative Regulator of RNAP III, Not Fully Functional?
por: Boguta, Magdalena
Publicado: (2015)

De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression
por: Friedersdorff, F., et al.
Publicado: (2010)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

Diagnosis of cross-reactivity in patients with birth pollinosis
por: Napiórkowska, Katarzyna, et al.
Publicado: (2011)

Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production
por: von Borstel, Anouk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sv04495qsjkal1s7bfd0ln2mr5